*Author Search Results*

sublabel_SolrAuthor

*Authority Data* (*EntityFactsFrom* GND / Entity Facts )

Dominik Bettinger

*born* 1985 *in* Rottweil
Arzt

*BiographicalDetails*
Diss. 2013, Universität Freiburg, Medizinische Fakultät

*placeOfActivity*
Freiburg im Breisgau

More Links

Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek

Open Researcher and Contributor ID (ORCID)

Deutsche Digitale Bibliothek

Virtual International Authority File (VIAF)

Wikidata

International Standard Name Identifier (ISNI)

1
2
3
4
5
*Next*
[5]

Albi grade enables risk stratification for bleeding events and refines prognostic prediction in advanced HCC following atezolizumab and bevacizumab

Stefanini, Bernardo (Verfasser)

Freiburg : Universität, 2025

*eBook*

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Wu, Yue Linda (Verfasser)

Freiburg : Universität, 2022

*eBook*

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

Marinelli, Brett (Verfasser)

Freiburg : Universität, 2022

*eBook*

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

Sharma, Rohini (Verfasser)

Freiburg : Universität, 2022

*eBook*

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Fulgenzi, Claudia Angela Maria (Verfasser)

Freiburg : Universität, 2022

*eBook*

The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma

Muhammed, Ambreen (Verfasser)

Freiburg : Universität, 2022

*eBook*

Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma

Fessas, Petros (Verfasser)

Freiburg : Universität, 2021

*eBook*

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy

Pinato, David James (Verfasser)

Freiburg : Universität, 2020

*eBook*

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

Fessas, Petros (Verfasser)

Freiburg : Universität, 2020

*eBook*

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

Labeur, Tim A. (Verfasser)

Freiburg : Universität, 2020

*eBook*

Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach

Han, Guohong (Verfasser)

Freiburg : Universität, 2020

*eBook*

Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade

Pinato, David James (Verfasser)

Freiburg : Universität, 2020

*eBook*

Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma

Sharma, Rohini (Verfasser)

Freiburg : Universität, 2025

*eBook*

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

Balcar, Lorenz (Verfasser)

Freiburg : Universität, 2024

*eBook*

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: an international observational study

Xia, Dongdong (Verfasser)

Freiburg : Universität, 2024

*eBook*

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study

Talbot, Thomas (Verfasser)

Freiburg : Universität, 2023

*eBook*

Impact of COVID-19 on 1-zear survival outcomes in hepatocellular carcinoma : : a multicenter cohort study

De Souza, Shuell (Verfasser)

Freiburg : Universität, 2023

*eBook*

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

Dharmapuri, Sirish (Verfasser)

Freiburg : Universität, 2024

*eBook*

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

Vithayathil, Mathew (Verfasser)

Freiburg : Universität, 2022

*eBook*

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study

D’Alessio, Antonio (Verfasser)

Freiburg : Universität, 2022

*eBook*

1
2
3
4
5
*Next*
[5]

*sublabel_SolrAuthor*

*Showing* 1 - 20 *of* 83

Dominik Bettinger

*More Links*

*pagination*

*pagination*

*Narrow Search*

sublabel_SolrAuthor

Showing 1 - 20 of 83

More Links

pagination

pagination

Narrow Search